RICHMOND, BRITISH COLUMBIA--(Marketwire - Sept. 17, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV) announces that its Metricath Libra® arterial and in-stent measurement system was used in a live clinical demonstration at a recent U.S. cardiovascular conference. The device was used during an interventional procedure of a patient’s peripheral arteries at the Capital Cardiovascular Conference (C3) in Harrisburg, PA.
